Suppr超能文献

老年人群经皮冠状动脉介入治疗的预后:多中心前瞻性e-ULTIMASTER注册研究结果

Prognosis of PCI in the Older Adult Population: Outcomes From the Multicenter Prospective e-ULTIMASTER Registry.

作者信息

Saada Majdi, Kobo Ofer, Kauer Floris, Sakhov Orazbek, Laanmets Peep, Abhaichand Rajpal, Lozano Iñigo, Crowley Jim, Wander Gurupreet Singh, Mamas Mamas A, Roguin Ariel

机构信息

Hillel Yaffe Medical Center, Technion-Faculty of Medicine, Israel.

Department of Cardiology, Albert Schweitzer Ziekenhuis, Dordrecht, the Netherlands.

出版信息

J Soc Cardiovasc Angiogr Interv. 2022 Aug 24;1(5):100442. doi: 10.1016/j.jscai.2022.100442. eCollection 2022 Sep-Oct.

Abstract

BACKGROUND

Older adult patients undergoing percutaneous coronary intervention (PCI) are usually excluded from clinical trials. This study aimed to assess 1-year clinical outcomes in patients aged >80 years.

METHODS

This all-comer registry included patients who underwent PCI using the Ultimaster stent. Primary clinical endpoint was target lesion failure (TLF), a composite of cardiac death (CD), target vessel-related myocardial infarction (TV-MI), or clinically indicated target lesion revascularization (CD-TLR).

RESULTS

In total, 3286 (8.8%) patients aged ≥80 years were compared with 33,912 patients aged <80 years. The older adult patients included more women, had more comorbidities and exhibited more complex coronary anatomy. The incidence of TLF was higher in the older adult group (5.6% vs 3.0%, < .0001), as well as for all-cause mortality (6.2% vs 1.7%, < .0001), CD (3.3% vs 1.1%, < .0001), and TV-MI (1.7% vs 0.8%, < .0001), but not for CD-TLR (1.9% vs 1.7%, = .15). After the inverse propensity score weighted analysis, aged ≥80 years was associated with increased risk of TLF (HR, 1.42; 95% CI, 1.22-1.66; < .0001), CD (HR, 1.67; 95% CI, 1.136-2.06; < .0001), and TV-MI (HR, 1.66; 95% CI, 1.24-2.24; < .001) but not for CD-TLR (HR, 1.10; 95% CI, 0.85-1.43; = .45).

CONCLUSION

Older adult patients had a higher incidence of TLF, CD, and TV-MI but with no difference in the incidence of recurrent revascularization or stent thrombosis. Although PCI in older adults is relatively safe, higher rates of cardiac events should be considered.

摘要

背景

接受经皮冠状动脉介入治疗(PCI)的老年患者通常被排除在临床试验之外。本研究旨在评估80岁以上患者的1年临床结局。

方法

该全人群注册研究纳入了使用Ultimaster支架接受PCI的患者。主要临床终点是靶病变失败(TLF),这是一个由心源性死亡(CD)、靶血管相关心肌梗死(TV-MI)或临床指征的靶病变血运重建(CD-TLR)组成的复合终点。

结果

总共将3286例(8.8%)年龄≥80岁的患者与33912例年龄<80岁的患者进行了比较。老年患者中女性更多,合并症更多,冠状动脉解剖结构更复杂。老年组的TLF发生率更高(5.6%对3.0%,P<0.0001),全因死亡率(6.2%对1.7%,P<0.0001)、CD(3.3%对1.1%,P<0.0001)和TV-MI(1.7%对0.8%,P<0.0001)也是如此,但CD-TLR发生率无差异(1.9%对1.7%,P=0.15)。在进行倾向评分逆加权分析后,年龄≥80岁与TLF风险增加相关(HR,1.42;95%CI,1.22-1.66;P<0.0001)、CD(HR,1.67;95%CI,1.136-2.06;P<0.0001)和TV-MI(HR,1.66;95%CI,1.24-2.24;P<0.001),但CD-TLR无差异(HR,1.10;95%CI,0.85-1.43;P=0.45)。

结论

老年患者的TLF、CD和TV-MI发生率较高,但再次血运重建或支架血栓形成的发生率无差异。虽然老年患者的PCI相对安全,但应考虑较高的心脏事件发生率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2712/11308062/199a19910287/fx1.jpg

相似文献

1
Prognosis of PCI in the Older Adult Population: Outcomes From the Multicenter Prospective e-ULTIMASTER Registry.
J Soc Cardiovasc Angiogr Interv. 2022 Aug 24;1(5):100442. doi: 10.1016/j.jscai.2022.100442. eCollection 2022 Sep-Oct.
2
5
Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.
JACC Cardiovasc Interv. 2013 Sep;6(9):905-13. doi: 10.1016/j.jcin.2013.04.017. Epub 2013 Aug 14.
8
Treatment of Ostial Right Coronary Artery Narrowings: Outcomes From the Multicenter Prospective e-ULTIMASTER Registry.
J Soc Cardiovasc Angiogr Interv. 2023 Feb 25;2(3):100604. doi: 10.1016/j.jscai.2023.100604. eCollection 2023 May-Jun.

本文引用的文献

1
Cardiovascular care of older adults.
BMJ. 2021 Aug 31;374:n1593. doi: 10.1136/bmj.n1593.
3
New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials.
Am Heart J. 2020 Oct;228:109-115. doi: 10.1016/j.ahj.2020.07.003. Epub 2020 Jul 12.
7
Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial.
Lancet. 2018 Jan 6;391(10115):41-50. doi: 10.1016/S0140-6736(17)32713-7. Epub 2017 Nov 1.
9
Safety and efficacy outcomes of second-generation everolimus-eluting stents in octogenarians compared to non-octogenarians.
Cardiovasc Revasc Med. 2018 Jan;19(1 Pt A):12-16. doi: 10.1016/j.carrev.2017.05.022. Epub 2017 Jun 1.
10
Drug-coated versus bare-metal stents for elderly patients: A predefined sub-study of the LEADERS FREE trial.
Int J Cardiol. 2017 Sep 15;243:110-115. doi: 10.1016/j.ijcard.2017.04.079. Epub 2017 Apr 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验